Advanced Heart Failure and Transplant Cardiology · Weston, FL
NPI
1699069088
Since 2011
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
3100 Weston Rd
Weston, FL, 33331
Phone (954) 659-5290
Groups this clinician bills Medicare through
Medicare paid, 2024
$134K
1,305 services
Medicare patients, 2024
254
Average age 72
Drug cost, 2024
$4.0M
1,766 prescriptions
Company payments, 2025
$61K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David F Snipelisky was code 99291 (critical care e&m), 210 times for 40 patients. In total David F Snipelisky billed 1,305 services in 25 codes, and Medicare paid $134K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99291 Critical Care E&M | Facility | 210 | 40 | $177.37 | $37K |
| 99215 Office E&M - Established | Facility | 201 | 100 | $113.06 | $23K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 194 | 108 | $13.55 | $2,629 |
| 99233 Hospital E&M - Subsequent | Facility | 191 | 40 | $97.73 | $19K |
| 93750 External Electrocardiographic Monitoring | Facility | 131 | 24 | $33.45 | $4,383 |
| 99215 Office E&M - Established | Office | 65 | 40 | $144.86 | $9,416 |
| 99214 Office E&M - Established | Facility | 54 | 37 | $69.54 | $3,755 |
| 93451 Percutaneous Transcatheterization | Facility | 53 | 49 | $105.98 | $5,617 |
| 93505 Cardiovascular | Facility | 39 | 19 | $193.06 | $7,529 |
| 99205 Office E&M - New | Facility | 36 | 36 | $149.46 | $5,381 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 29 | 20 | $13.55 | $393 |
| 99223 Hospital E&M - Initial | Facility | 23 | 18 | $142.80 | $3,284 |
| 99214 Office E&M - Established | Office | 19 | 16 | $86.31 | $1,640 |
| 99239 Hospital Discharge Management | Facility | 18 | 16 | $91.97 | $1,656 |
By year: 2022 $105K for 983 services; 2023 $111K for 865 services; 2024 $134K for 1,305 services.
Medicare prescription drug claims, 2024
In 2024, the drug David F Snipelisky prescribed most often to Medicare patients was Entresto (Sacubitril/Valsartan), with 246 prescriptions and refills. In total David F Snipelisky wrote 1,766 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Entresto Sacubitril/Valsartan | 246 | 424 | 65 | $279K |
| Spironolactone Generic | 163 | 398 | 55 | $1,163 |
| Metoprolol Succinate Generic | 146 | 362 | 50 | $1,614 |
| Vyndamax Tafamidis | 118 | 124 | 16 | $2.7M |
| Farxiga Dapagliflozin Propanediol | 111 | 195 | 30 | $108K |
| Eliquis Apixaban | 81 | 133 | 24 | $75K |
| Furosemide Generic | 79 | 209 | 37 | $434 |
| Torsemide Generic | 78 | 163 | 29 | $2,038 |
| Atorvastatin Calcium Generic | 60 | 166 | 20 | $876 |
| Carvedilol Generic | 53 | 134 | 21 | $461 |
| Jardiance Empagliflozin | 53 | 95 | 14 | $51K |
| Losartan Potassium Generic | 42 | 107 | 15 | $327 |
| Amlodipine Besylate Generic | 40 | 85 | 17 | $112 |
| Hydralazine Hcl Generic | 32 | 84 | 19 | $332 |
| Milrinone Lactate Generic | 28 | 28 | Under 11 | $2,901 |
Brand drugs: 703 claims; generic drugs: 1,063 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David F Snipelisky $61K ($61K in general payments such as food, travel and fees) from 14 companies. The largest payer was Pfizer Inc. with $58K.
| Company | Payments | Amount |
|---|---|---|
| Pfizer Inc. PFE | 67 | $58K |
| Abbott Laboratories ABT | 7 | $499 |
| Impulse Dynamics (USA) Inc. | 3 | $489 |
| Medtronic, Inc. MDT | 6 | $423 |
| Biosense Webster, Inc. JNJ | 11 | $422 |
| Boston Scientific Corporation BSX | 3 | $100 |
| BridgeBio Pharma, Inc. BBIO | 4 | $95.95 |
| Cordis US Corp. JNJ | 1 | $86.96 |
| Endotronix, Inc. | 1 | $82.6 |
| Amgen Inc. AMGN | 2 | $34.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.